How changes in gene regulation affect inflammation and healing in diabetic wounds
Epigenetic Regulation of Prostaglandin E2 (PGE2) Synthesis Alters Macrophage Function to Promote Inflammation and Impair Diabetic Wound Healing
This study is looking at why some wounds don’t heal well in people with Type 2 Diabetes and how certain immune cells and a substance called prostaglandin E2 might be involved, with the goal of finding better ways to help these wounds heal.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10599942 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind non-healing wounds in patients with Type 2 Diabetes (T2D), which can lead to serious complications like amputation. By studying both animal models and human samples, the research focuses on how macrophages, a type of immune cell, function in the context of diabetes. The team is particularly interested in the role of prostaglandin E2 (PGE2), a lipid that can promote inflammation and impair healing. Through understanding these processes, the research aims to identify potential therapeutic targets to improve wound healing in diabetic patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with Type 2 Diabetes who experience non-healing wounds.
Not a fit: Patients without Type 2 Diabetes or those with wounds not related to diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance wound healing and reduce the risk of amputation for patients with Type 2 Diabetes.
How similar studies have performed: Previous research has shown promising results in understanding the role of macrophages in wound healing, suggesting that this approach could yield significant insights.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Gallagher, Katherine Ann — University of Michigan at Ann Arbor
- Study coordinator: Gallagher, Katherine Ann
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.